Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ICU MEDICAL INC/DEICUI · Entity 2385 | Director | May 13, 2026 | May 14, 2026 |
| IPG PHOTONICS CORPIPGP · Entity 1767 | Director | May 12, 2026 | May 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ICU MEDICAL INC/DE
Report date May 13, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,539 |
Reported balance
After 2026-05-13 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-13 · Exercise / conversion · Acquired 1,254 · Balance 4,539 F1: These securities are Restricted Stock Units. F2: There is neither a purchase price nor an exercise price for Restricted Stock Units. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-05-13 | Direct | 0 |
Reported balance
After 2026-05-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-13 · Exercise / conversion · Disposed 1,254 · Balance 0 F1: These securities are Restricted Stock Units. F2: There is neither a purchase price nor an exercise price for Restricted Stock Units. F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-05-13 | Direct | 1,475 |
Reported balance
After 2026-05-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-13 · Grant · Acquired 1,475 · Balance 1,475 F1: These securities are Restricted Stock Units. F2: There is neither a purchase price nor an exercise price for Restricted Stock Units. F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are Restricted Stock Units.
F2: There is neither a purchase price nor an exercise price for Restricted Stock Units.
F3: These awards vest on the anniversary of the date of the grant or the following annual stockholder meeting, whichever occurs first.
IPG PHOTONICS CORP
Report date May 12, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,513 |
Reported balance
After 2026-05-12 transaction · row 1
1 source rowRow 1 · 2026-05-12 · Grant · Acquired 2,436 · Balance 11,513 F1: Grant of restricted stock units vesting in full on the earlier of the first anniversary of the grant date or the next annual stockholders' meeting that occurs at least 50 weeks after the prior year's meeting, subject to the Reporting Person's continued services as a director of the Issuer through the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units vesting in full on the earlier of the first anniversary of the grant date or the next annual stockholders' meeting that occurs at least 50 weeks after the prior year's meeting, subject to the Reporting Person's continued services as a director of the Issuer through the vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
VARIAN MEDICAL SYSTEMS INC
Report date April 15, 2021 · Filed April 16, 2021
Section 16 reporting ended · disclosed 2021-04-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 1
1 source rowRow 1 · 2021-04-15 · Disposition to issuer · Disposed 29,249 · Balance 0 F1: Amount of securities beneficially owned at end of reporting period reflect a reduction of 7 shares as a result of a tax correction for the February 16, 2021 RSU vesting. F2: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock. |
| Non Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $64.68 · Expires 2025-02-08 | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-04-15 · Disposition to issuer · Disposed 1,630 · Balance 0 F3: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/8/2019, and the remaining shares in 24 equal installments over the 24 months following, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock. |
| Non Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.73 · Expires 2026-02-14 | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-04-15 · Disposition to issuer · Disposed 6,002 · Balance 0 F4: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/14/2020, and the remaining shares in 24 equal installments over the 24 months following, were canceled in exchange for a cash award representing the difference between $177.50 and the exercise price of the option of the underlying common stock. |
| Non Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.59 · Expires 2027-02-13 | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-04-15 · Disposition to issuer · Disposed 14,122 · Balance 0 F5: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/13/2021, and the remaining shares in 24 equal installments over the 24 months following, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-04-15 · Disposition to issuer · Disposed 1,063 · Balance 0 F6: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F7: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 14, 2020, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-04-15 · Disposition to issuer · Disposed 12,103 · Balance 0 F6: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F8: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-04-15 · Disposition to issuer · Disposed 1,906 · Balance 0 F6: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F9: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 15, 2021, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-04-15 · Disposition to issuer · Disposed 8,859 · Balance 0 F10: Each performance stock unit represents a contingent right to receive one share of VAR common stock. F11: Pursuant to the Merger Agreement, these performance stock units, which were granted November 21, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-04-15 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2021-04-15 · Disposition to issuer · Disposed 10,777 · Balance 0 F10: Each performance stock unit represents a contingent right to receive one share of VAR common stock. F12: Pursuant to the Merger Agreement, these performance stock units, which were granted November 15, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level. |
Filing footnotes · ownership attribution and instrument terms
F1: Amount of securities beneficially owned at end of reporting period reflect a reduction of 7 shares as a result of a tax correction for the February 16, 2021 RSU vesting.
F2: Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.
F3: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/8/2019, and the remaining shares in 24 equal installments over the 24 months following, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock.
F4: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/14/2020, and the remaining shares in 24 equal installments over the 24 months following, were canceled in exchange for a cash award representing the difference between $177.50 and the exercise price of the option of the underlying common stock.
F5: Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/13/2021, and the remaining shares in 24 equal installments over the 24 months following, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock.
F6: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
F7: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 14, 2020, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
F8: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule.
F9: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 15, 2021, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
F10: Each performance stock unit represents a contingent right to receive one share of VAR common stock.
F11: Pursuant to the Merger Agreement, these performance stock units, which were granted November 21, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
F12: Pursuant to the Merger Agreement, these performance stock units, which were granted November 15, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 12, 2017 Filed Sep 13, 2017 11:25 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,088 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-027364 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| September 12, 2017 Filed Sep 19, 2017 20:36 UTC Amendment | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 1,088 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-17-027789 · form4a.xml · derivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,495 Underlying: Common Stock · 1,088 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| September 12, 2017 Filed Sep 19, 2017 20:36 UTC Amendment | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,088 | $67.12 | $73,026.56 |
DisclosureSEC source: 0001127602-17-027789 · form4a.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The amended Form 4 is being filed to disclose the acquisition price of the Common Stock. The shares were acquired by exercising Non-Qualified Stock Options, and the acquisition price is the exercise price of the Non-Qualified Stock Option. The original Form 4 inadvertently disclosed that the shares were acquired at a price of $0; however, the exercise price of the Non-Qualified Stock Option was properly stated in Table II as $67.12. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 15:48 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 931 | $0.00 Strike: $81.97 | $0.00 |
DisclosureSEC source: 0001127602-17-026832 · form4.xml · derivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,593 Underlying: Common Stock · 931 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 2/13/2016, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 15:48 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 931 | $105.00 | $97,755.00 |
DisclosureSEC source: 0001127602-17-026832 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,600 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| August 31, 2017 Filed Sep 1, 2017 15:48 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 931 | $81.97 | $76,314.07 |
DisclosureSEC source: 0001127602-17-026832 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| August 14, 2017 Filed Aug 15, 2017 19:56 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 1,088 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-17-025683 · form4.xml · derivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,583 Underlying: Common Stock · 1,088 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| August 14, 2017 Filed Aug 15, 2017 19:56 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 1,088 | $97.91 | $106,524.77 |
DisclosureSEC source: 0001127602-17-025683 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,600 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 1,088 shares were sold in multiple transactions executed on the same day at prices ranging from $97.60 to $98.23. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| August 14, 2017 Filed Aug 15, 2017 19:56 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,088 | $67.12 | $73,026.56 |
DisclosureSEC source: 0001127602-17-025683 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| July 13, 2017 Filed Jul 13, 2017 19:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 933 | $0.00 Strike: $81.97 | $0.00 |
DisclosureSEC source: 0001127602-17-023585 · form4.xml · derivative · entry 6 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,524 Underlying: Common Stock · 933 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 2/13/2016, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| July 13, 2017 Filed Jul 13, 2017 19:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 933 | $105.00 | $97,965.00 |
DisclosureSEC source: 0001127602-17-023585 · form4.xml · nonDerivative · entry 4 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,600 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| July 13, 2017 Filed Jul 13, 2017 19:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 933 | $81.97 | $76,478.01 |
DisclosureSEC source: 0001127602-17-023585 · form4.xml · nonDerivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| July 12, 2017 Filed Jul 13, 2017 19:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 1,088 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-17-023585 · form4.xml · derivative · entry 5 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,671 Underlying: Common Stock · 1,088 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| July 12, 2017 Filed Jul 13, 2017 19:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 1,088 | $104.49 | $113,689.69 |
DisclosureSEC source: 0001127602-17-023585 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,600 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 1,088 shares were sold in multiple transactions executed on the same day at prices ranging from $104.29 to $104.61. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| July 12, 2017 Filed Jul 13, 2017 19:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,088 | $67.12 | $73,026.56 |
DisclosureSEC source: 0001127602-17-023585 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 16:49 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 26,092 | $0.00 Strike: $81.97 | $0.00 |
DisclosureSEC source: 0001127602-17-022004 · form4.xml · derivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,457 Underlying: Common Stock · 26,092 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent. F3 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 2/13/2016, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. F2 · derivative.underlying_shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent. Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 16:49 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 26,092 | $105.00 | $2,739,660.00 |
DisclosureSEC source: 0001127602-17-022004 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,600 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 16:49 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 26,092 | $81.97 | $2,138,761.24 |
DisclosureSEC source: 0001127602-17-022004 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent. F2 · price: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 19:07 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 1,087 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-17-021373 · form4.xml · derivative · entry 4 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,759 Underlying: Common Stock · 1,087 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 19:07 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 100 | $101.99 | $10,199.00 |
DisclosureSEC source: 0001127602-17-021373 · form4.xml · nonDerivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,600 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 19:07 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 987 | $101.12 | $99,800.70 |
DisclosureSEC source: 0001127602-17-021373 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,700 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · price: The 987 shares were sold in multiple transactions executed on the same day at prices ranging from $100.52 to $101.46. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 19:07 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,087 | $67.12 | $72,959.44 |
DisclosureSEC source: 0001127602-17-021373 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,687 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 34,118 | $0.00 Strike: $74.06 | $0.00 |
DisclosureSEC source: 0001127602-17-020394 · form4.xml · derivative · entry 12 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,118 shares Expires 2021-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent. F10 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 02/21/2015, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. F2 · derivative.underlying_shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 16,318 | $0.00 Strike: $67.12 | $0.00 |
DisclosureSEC source: 0001127602-17-020394 · form4.xml · derivative · entry 11 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,846 Underlying: Common Stock · 16,318 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent. F9 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/12/2017, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. F2 · derivative.underlying_shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 6,137 | $0.00 Strike: $60.91 | $0.00 |
DisclosureSEC source: 0001127602-17-020394 · form4.xml · derivative · entry 10 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,137 shares Expires 2019-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent. F8 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Third Amended and Restated 2005 Omnibus Stock Plan, which complies with Rule 16b-3. The option vests as follows: one third on 11/09/2013, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. F2 · derivative.underlying_shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 20,111 | $100.17 | $2,014,567.14 |
DisclosureSEC source: 0001127602-17-020394 · form4.xml · nonDerivative · entry 9 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,600 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F6 · price: The 20,111 shares were sold in multiple transactions executed on the same day at prices ranging from $99.67 to $100.66. The detailed breakdown of executed sales will be furnished upon request. F7 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 241 shares purchased on April 28, 2017 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 13,607 | $99.18 | $1,349,607.57 |
DisclosureSEC source: 0001127602-17-020394 · form4.xml · nonDerivative · entry 8 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,711 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F5 · price: The 13,607 shares were sold in multiple transactions executed on the same day at prices ranging from $98.66 to $99.65. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 400 | $98.63 | $39,452.00 |
DisclosureSEC source: 0001127602-17-020394 · form4.xml · nonDerivative · entry 7 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,318 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 100 | $100.69 | $10,069.00 |
DisclosureSEC source: 0001127602-17-020394 · form4.xml · nonDerivative · entry 6 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,718 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 13,250 | $100.17 | $1,327,317.43 |
DisclosureSEC source: 0001127602-17-020394 · form4.xml · nonDerivative · entry 5 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,818 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F4 · price: The 13,250 shares were sold in multiple transactions executed on the same day at prices ranging from $99.65 to $100.64. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | SaleCommon Stock | 9,105 | $99.16 | $902,887.31 |
DisclosureSEC source: 0001127602-17-020394 · form4.xml · nonDerivative · entry 4 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,068 F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F3 · price: The 9,105 shares were sold in multiple transactions executed on the same day at prices ranging from $98.63 to $99.61. The detailed breakdown of executed sales will be furnished upon request. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 34,118 | $74.06 | $2,526,779.08 |
DisclosureSEC source: 0001127602-17-020394 · form4.xml · nonDerivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent. F2 · price: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 16,318 | $67.12 | $1,095,264.16 |
DisclosureSEC source: 0001127602-17-020394 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent. F2 · price: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 18:59 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 6,137 | $60.91 | $373,804.67 |
DisclosureSEC source: 0001127602-17-020394 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,737 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction is pursuant to the filer's SEC Rule10b5-1 Stock Plan F2 · shares: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent. F2 · price: The stock options were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Stock options that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding down to the nearest whole share, and dividing the per share exercise price by 1.1303 and rounding up to the nearest cent. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 20:44 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 1,344 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-006737 · form4.xml · derivative · entry 7 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,976 Underlying: Common Stock · 1,344 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F5 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2017, February 15, 2018, and February 15, 2019. Vested shares will be delivered to the reporting person on vest date. F5 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2017, February 15, 2018, and February 15, 2019. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 20:44 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 2,237 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-006737 · form4.xml · derivative · entry 6 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,320 Underlying: Common Stock · 2,237 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F4 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2016, February 15, 2017, and February 15, 2018. Vested shares will be delivered to the reporting person on vest date. F4 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2016, February 15, 2017, and February 15, 2018. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 20:44 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionRestricted Stock Units · Derivative | 2,476 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-006737 · form4.xml · derivative · entry 5 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,557 Underlying: Common Stock · 2,476 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2015, February 15, 2016, and February 15, 2017. Vested shares will be delivered to the reporting person on vest date. F3 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2015, February 15, 2016, and February 15, 2017. Vested shares will be delivered to the reporting person on vest date. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 20:44 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 2,160 | $81.12 | $175,219.20 |
DisclosureSEC source: 0001127602-17-006737 · form4.xml · nonDerivative · entry 4 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,359 F2 · shares: Represents shares withheld from vested restricted stock units for the payment of federal, state and payroll taxes due on vesting. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 20:44 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 1,344 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-006737 · form4.xml · nonDerivative · entry 3 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,519 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 20:44 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 2,237 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-006737 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 20:44 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Exercise / conversionCommon Stock | 2,476 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-006737 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 18:27 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantRestricted Stock Units · Derivative | 5,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-006143 · form4.xml · derivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,033 Underlying: Common Stock · 5,050 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3 · derivative.exercise_date: The restricted stock units vest in three equal installments on February 15, 2018, February 15, 2019, and February 15, 2020. Vested shares will be delivered to the reporting person on vest date. F3 · derivative.expiration_date: The restricted stock units vest in three equal installments on February 15, 2018, February 15, 2019, and February 15, 2020. Vested shares will be delivered to the reporting person on vest date. F4 · balance_after: Includes restricted stock units that were adjusted pursuant to the Employee Matters Agreement between Varian Medical Systems, Inc. ("Varian") and Varex Imaging Corporation ("Varex") relating to the January 28, 2017 distribution by Varian to its stockholders of all of the outstanding shares of the common stock of Varex. Restricted stock units that were outstanding at the time of the distribution were adjusted by multiplying the number of shares subject thereto by 1.1303 and rounding to the nearest whole share. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 18:27 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 25,170 | $0.00 Strike: $80.40 | $0.00 |
DisclosureSEC source: 0001127602-17-006143 · form4.xml · derivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,170 Underlying: Common Stock · 25,170 shares Expires 2024-02-10 F1 · derivative.exercise_date: Stock option granted under the Varian Medical Systems, Inc. Fourth Amended and Restated 2005 Omnibus Stock Plan which complies with Rule 16b-3. The option vests as follows: one third on 2/10/2018, and the remaining shares in 24 equal installments over the 24 months following the first vesting date. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 17:13 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | Tax withholdingCommon Stock | 1,063 | $88.25 | $93,809.75 |
DisclosureSEC source: 0001127602-16-067913 · form4.xml · nonDerivative · entry 2 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,462 F2 · shares: Represents shares withheld from vested PSUs for the payment of federal, state and payroll taxes due on settlement. F3 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 232 shares purchased on April 29, 2016 and 153 shares purchased on October 28, 2016 under the Varian Medical Systems, Inc. Employee Stock Purchase Plan. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 17:13 UTC | VARIAN MEDICAL SYSTEMS INC VAR · Entity 140252 | GrantCommon Stock | 2,831 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-067913 · form4.xml · nonDerivative · entry 1 KENNEDY KOLLEEN T · CIK 0001531738 · EVP and Pres. Oncology Sys. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,525 F1 · shares: Represents shares issued upon settlement of performance-based unit award (PSUs) granted November 20, 2013. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.